In 1982, the U.S. Food and Drug Administration (FDA) approved Accutane for the treatment of severe, recalcitrant nodular acne ...

Cip-isotretinoin is indicated for the treatment of severe recalcitrant nodular acne. It is expected to be available in the United States in the fourth quarter of 2012 under the brand name Absorica.

D.A. Dear D.A.: Isotretinoin (Accutane in Canada, several brands in the U.S.) is a powerful treatment for acne, a derivative of vitamin A. It is indicated for severe, recalcitrant nodular acne ...

Dr. Reddy’s has announced the relaunch of Zenatane (isotretinoin capsules) for the treatment of severe recalcitrant nodular acne unresponsive to conventional therapy (eg, systemic antibiotics).

Image: Adobe Stock. Approved for the treatment of severe recalcitrant nodular acne in patients aged 12 years and older, micronized isotretinoin 0.4 mg/kg to 0.8 mg/kg diffused in a lipid carrier ...

In September 1982, the US Food and Drug Administration (FDA) approved the drug isotretinoin (Accutane) for use in the treatment of severe recalcitrant nodular acne. Accutane, taken orally over 20 ...

Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of ...

The product is indicated for the management of severe recalcitrant nodular acne in patients 12 years of age and older. Absorica LD is the only isotretinoin formulation to feature Sun Pharma’s ...

The program is designed to reduce the risk of fetal exposure to isotretinoin, or Accutane, a drug used to treat severe recalcitrant nodular acne. Those changes include eliminating the 23-day ...